AHR and ovarian carcinoma: The AhR is expressed at high levels and is chronically active in blood tumors (58, 59), such as T-cell leukemia (60) and lymphoma (61), as well as in solid tumors such as glioblastoma (14), ovarian cancer (51), lung cancer (62), liver cancer (63), and head and neck carcinomas (58).